Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07527208 · ClinicalTrials.gov registry record · NA
The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial
A NA study, sponsored by Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07527208 is a NA study that is actively recruiting participants, run by Cornell University. The registered enrollment target is 28 participants.
The verdict
NCT07527208, a NA study, is actively recruiting participants, sponsored by Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
During fasting, the body shifts from using carbohydrates to relying more on fat as its main source of energy. This process is known as the 'metabolic shift'. Fat tissue helps supply this energy by breaking down stored fat into fatty acids, which are released into the bloodstream and transported to organs throughout the body. In addition to fatty acids, many other substances in the blood (such as metabolites) change during fasting to help maintain normal body function. Immune cells also circulate in the blood and play an important role in protecting the body against infections and diseases such as cancer. However, it is not yet well understood how the metabolic shift during fasting affects immune cell function. The purpose of this study is to investigate how 24 hours of fasting influences immune cell metabolism and function.
Interventions
- OTHER Fasting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07527208
The ClinicalTrials.gov registry entry for NCT07527208 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fasting is the first listed.
NCT07527208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07527208 about?
NCT07527208 is a clinical study titled "The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial". During fasting, the body shifts from using carbohydrates to relying more on fat as its main source of energy. This process is known as the 'metabolic shift'. Fat tissue helps supply this energy by breaking down stored fat into fatty acids, which are released into the bloodstream and transported to o...
What is the current status of trial NCT07527208?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-06-01. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07527208?
The interventions under investigation include: Fasting (OTHER).
Who is sponsoring clinical trial NCT07527208?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.